These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

562 related articles for article (PubMed ID: 15611795)

  • 21. [A new sequential chemotherapy of methotrexate with 5-fluorouracil against advanced colo-rectal cancer].
    Fujiki T; Futatsuki K; Akazawa S; Yamamoto K; Miyazaki M; Kanda Y; Amemiya K; Uchida N; Oishi T
    Gan To Kagaku Ryoho; 1993 Apr; 20(5):603-9. PubMed ID: 8470917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluorouracil plus leucovorin as effective adjuvant chemotherapy in curatively resected stage III colon cancer: results of the trial adjCCA-01.
    Porschen R; Bermann A; Löffler T; Haack G; Rettig K; Anger Y; Strohmeyer G;
    J Clin Oncol; 2001 Mar; 19(6):1787-94. PubMed ID: 11251010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
    Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
    Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinoma.
    Scheithauer W; Kornek GV; Marczell A; Karner J; Salem G; Greiner R; Burger D; Stöger F; Ritschel J; Kovats E; Vischer HM; Schneeweiss B; Depisch D
    Br J Cancer; 1998 Apr; 77(8):1349-54. PubMed ID: 9579845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomised study of tegafur and oral leucovorin versus intravenous 5-fluorouracil and leucovorin in patients with advanced colorectal cancer.
    Nogué M; Salud A; Batiste-Alentorn E; Saigí E; Losa F; Cirera L; Méndez M; Campos JM; Galan A; Escudero P; Arcusa A; Manzano H; de Mendizábal EV; de Olaguer JP; Boleda M; Guasch I; Vicente P
    Eur J Cancer; 2005 Oct; 41(15):2241-9. PubMed ID: 16214045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III.
    Taal BG; Van Tinteren H; Zoetmulder FA;
    Br J Cancer; 2001 Nov; 85(10):1437-43. PubMed ID: 11720425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant chemotherapy with cisplatin, etoposide, fluorouracil and leucovorin for gastric carcinoma.
    Papadakou M; Xydakis E; Bonios M; Makropoulou E; Boukis C; Kakavoulis T; Karaliotas C; Panagos G
    J BUON; 2006; 11(3):285-9. PubMed ID: 17309151
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase III study of cyclophosphamide, doxorubicin, and fluorouracil (CAF) plus leucovorin versus CAF for metastatic breast cancer: Cancer and Leukemia Group B 9140.
    Parnes HL; Cirrincione C; Aisner J; Berry DA; Allen SL; Abrams J; Chuang E; Cooper MR; Perry MC; Duggan DB; Szatrowski TP; Henderson IC; Norton L;
    J Clin Oncol; 2003 May; 21(9):1819-24. PubMed ID: 12721259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative chemoradiotherapy for rectal cancer: randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil and leucovorin.
    de la Torre A; García-Berrocal MI; Arias F; Mariño A; Valcárcel F; Magallón R; Regueiro CA; Romero J; Zapata I; de la Fuente C; Fernández-Lizarbe E; Vergara G; Belinchón B; Veiras M; Molerón R; Millán I
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):102-10. PubMed ID: 17869446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-Fluorouracil plus leucovorin is an effective adjuvant chemotherapy in curatively resected stage III colon cancer: long-term follow-up results of the adjCCA-01 trial.
    Arkenau HT; Bermann A; Rettig K; Strohmeyer G; Porschen R;
    Ann Oncol; 2003 Mar; 14(3):395-9. PubMed ID: 12598344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longitudinal quality of life and quality adjusted survival in a randomised controlled trial comparing six months of bolus fluorouracil/leucovorin vs. twelve weeks of protracted venous infusion fluorouracil as adjuvant chemotherapy for colorectal cancer.
    Chau I; Norman AR; Cunningham D; Iveson T; Hill M; Hickish T; Lofts F; Jodrell D; Webb A; Tait D; Ross PJ; Shellito P; Oates JR
    Eur J Cancer; 2005 Jul; 41(11):1551-9. PubMed ID: 16026692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pilot study of adjuvant chemotherapy with double modulation of 5-fluorouracil by methotrexate and leucovorin in gastric cancer patients.
    De Vita F; Orditura M; Auriemma A; Infusino S; Catalano G
    Panminerva Med; 1999 Mar; 41(1):35-8. PubMed ID: 10230255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The toxicity and efficacy of Nordic-FLOX regimen as adjuvant treatment of stage III colon cancer.
    Demir L; Somali I; Oktay Tarhan M; Erten C; Ellidokuz H; Can A; Dirican A; Vedat Bayoglu I
    J BUON; 2011; 16(4):682-8. PubMed ID: 22331722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II study of sequential methotrexate and 5-FU plus mitomycin and leucovorin in patients with disseminated large bowel cancer: a Northern California Oncology Group study.
    Ignoffo RJ; Friedman MA; Gribble M; Hannigan J; Reynolds R; Yu KP; Schiff S; Congdon JE
    Cancer Treat Rep; 1984; 68(7-8):983-8. PubMed ID: 6611204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II study.
    Taïeb J; Artru P; Paye F; Louvet C; Perez N; André T; Gayet B; Hebbar M; Goebel FM; Tournigand C; Parc R; de Gramont A
    J Clin Oncol; 2005 Jan; 23(3):502-9. PubMed ID: 15659495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Sequential methotrexate-5-fluorouracil (MTX-5-FU) treatment of patients with advanced gastric and colorectal cancer. Sequential Methotrexate-5-FU Study Group].
    Murakami M; Ota K; Miyazaki T; Niitsu Y; Wakui A; Yokoyama M; Kanamaru R; Futatsuki K; Akazawa S; Sakai Y
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2482-90. PubMed ID: 3619460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case of colon cancer recurrence with P-glycoprotein treated by methotrexate, fluorouracil, and leucovorin.
    Tokunaga Y; Ryo J; Kitaoka A; Yagi T; Tokuka A; Ohsumi K
    Hepatogastroenterology; 1999; 46(27):1736-9. PubMed ID: 10430334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Raltitrexed (Tomudex) versus standard leucovorin-modulated bolus 5-fluorouracil: Results from the randomised phase III Pan-European Trial in Adjuvant Colon Cancer 01 (PETACC-1).
    Popov I; Carrato A; Sobrero A; Vincent M; Kerr D; Labianca R; Raffaele Bianco A; El-Serafi M; Bedenne L; Paillot B; Mini E; Sanches E; Welch J; Collette L; Praet M; Wils J
    Eur J Cancer; 2008 Oct; 44(15):2204-11. PubMed ID: 18707870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase I/II study of oxaliplatin with weekly bolus fluorouracil and high-dose leucovorin (ROX) as first-line therapy for patients with colorectal cancer.
    Yamada Y; Ohtsu A; Boku N; Miyata Y; Shimada Y; Doi T; Muro K; Muto M; Hamaguchi T; Mera K; Yano T; Tanigawara Y; Shirao K
    Jpn J Clin Oncol; 2006 Apr; 36(4):218-23. PubMed ID: 16684860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A randomized comparative study of surgical adjuvant chemotherapy using 5-fluorouracil and dl-leucovorin with CDDP 5-FU and dl-leucovorin for colorectal cancer].
    Okabo S; Arai T; Maruyama S; Lee M; Murase N; Tsubaki M; Endo M; Wada Y; Shimoju K; Sakurazawa K; Sugihara K; Maruyama M; Yabata E; Kawasaki T; Sasaki T
    Gan To Kagaku Ryoho; 1997 May; 24(7):849-54. PubMed ID: 9170524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.